Background illustration for clinical trials search

Endocrine Clinical Trials

Browse 341 endocrine clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Coping Skills Training for Symptom Management and Daily Steps (Step Up)

for
Hematopoietic Stem Cell Transplant, CAR-T Cell Therapy
Location: Durham NC
Sponsor: Duke University

Sex: All

Age: 18 - 70+

Code: NCT06575712

Recruiting

Project: Every Child for Younger Patients With Cancer

for
Adrenal Gland Pheochromocytoma, Carcinoma In Situ,
Location: St. John's, Halifax, Bangor ME, Scarborough ME,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 25

Code: NCT02402244

Recruiting

Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer

for
Locoregional Recurrence,
Location: Boston MA, New York NY, New Brunswick NJ, Hershey PA,
Sponsor: Oana Danciu

Sex: All

Age: 18+

Code: NCT05467891

Phase2, Recruiting

Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

for
Breast Cancer, Breast Cancer Metastatic,
Location: Boston MA, Durham NC, Buffalo NY, Orlando FL,
Sponsor: Incyclix Bio

Sex: All

Age: 18+

Code: NCT05735080

Phase1, Phase2, Recruiting

Inhaled Insulin vs Rapid-acting Injections for Post-meal Glucose Control in Women With Gestational Diabetes

for
Diabetes, Gestational, Pregnancy Complications,
Location: New York City NY, Philadelphia PA, Aurora CO,
Sponsor: Jaeb Center for Health Research

Sex: Female

Age: 18 - 40

Code: NCT06535789

Phase2, Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA

for
Growth Hormone Deficiency
Location: Manchester NH, Lebanon NH, New Hyde Park NY,
Sponsor: Ascendis Pharma Endocrinology Division A/S

Sex: All

Age: 0+

Code: NCT05820672

Recruiting

Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)

for
Advanced Cancer, Anal Carcinoma, Anal Cancer, Biliary Cancer,
Location: New Brunswick NJ
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT02628067

Phase2, Recruiting

Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer

for
Breast Cancer, Breast Neoplasm, Breast Cancer Female,
Location: Houston TX
Sponsor: Baylor Breast Care Center

Sex: All

Age: 18+

Code: NCT05020860

Phase2, Recruiting

Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors

for
Metastatic Malignant Neoplasm in the Liver,
Location: Westerly RI, Waterford CT, Guilford CT, Glastonbury CT,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05040360

Phase2, Recruiting

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

for
Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma,
Location: Peabody MA, Burlington MA, Commack NY, Uniondale NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT03866382

Phase2, Recruiting

BettER: Biomarker Driven Early Therapeutic Selection in Patients With HR+ HER2- Metastatic or Unresectable Breast Cancer

for
Metastatic Breast Cancer, Unresectable Breast Cancer
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT05977036

Recruiting

SRS & Abemaciclib w/wo Imlunestrant in the Management of HR+/HER2- Breast CA Brain Metastases

for
Brain Metastases, HR+ Metastatic Breast Cancer
Location: Columbus OH
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 18+

Code: NCT04923542

Phase1, Phase2, Recruiting

Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort

for
Invasive Mammary Carcinoma, Metastatic Breast Cancer
Location: Birmingham AL, Nashville TN, Dallas TX
Sponsor: Sonya Reid

Sex: All

Age: 18+

Code: NCT05693766

Phase2, Recruiting

Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers

for
Anatomic Stage I Breast Cancer, Anatomic Stage II Breast Cancer,
Location: Nashville TN, Dallas TX
Sponsor: Vanderbilt-Ingram Cancer Center

Sex: All

Age: 18+

Code: NCT05919108

Phase2, Recruiting

Development of Patient Derived Xenografts (PDX) in Patients With Breast Cancer

for
Breast Cancer, Residual
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT04703244

Recruiting

Engaging M-health for Symptom Monitoring and Health Promotion for Women on Endocrine Therapy for Breast Cancer (EmSHAPE)

for
Cancer
Location: Philadelphia PA
Sponsor: Abramson Cancer Center at Penn Medicine

Sex: Female

Age: 18+

Code: NCT07454499

Recruiting

A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast Cancer

for
Breast Cancer, HER2-negative Breast Cancer,
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: Female

Age: 50+

Code: NCT07483307

Phase2, Recruiting

Evaluating Harms and Benefits of Endocrine Therapy in Patients ≥70 Years of Age With Lower Risk Breast Cancer

for
Breast Cancer
Location: Ottawa
Sponsor: Ottawa Hospital Research Institute

Sex: All

Age: 70+

Code: NCT04921137

Recruiting

Concurrent Neoadjuvant Chemo/Endocrine Therapy in HER2+ Breast Cancer

for
Breast Cancer - Infiltrating Ductal Carcinoma,
Location: Gresham OR, Vancouver WA, Portland OR, Tualatin OR
Sponsor: Legacy Health System

Sex: All

Age: 18+

Code: NCT07506876

Phase2, Recruiting

The Efficacy and Safety of Faster Insulin Aspart (Fiasp®) Compared to Conventional Insulin Aspart (NovoLog®) as Correction Bolus

for
Type 1 Diabetes Mellitus
Location: Asheville NC
Sponsor: Mountain Diabetes and Endocrine Center

Sex: All

Age: 18+

Code: NCT04414579

Recruiting